News

Bugs vs. Drugs: How Our Microbiomes Can Explain Our Response to Statins

Bugs vs. drugs – In this video, Dr. Sean Gibbons explains how our unique gut microbiomes shape our personalized responses to statins.

Statins are one of the most prescribed drugs in the developed world and have proven to be effective in lowering cholesterol levels and decreasing the risks of heart attack and stroke. However, like antibiotics, there is a flip side to their use. Side effects of statin use, for example, include an increased risk of developing type 2 diabetes.

ISB Assistant Professor Dr. Sean Gibbons talked about the science behind statins in our most recent Research Roundtable virtual presentation. His talk was titled “Bugs vs. Drugs – How Our Unique Gut Microbiomes Shape Our Personalized Responses to Statins.”

Gibbons discussed recent research out of ISB and published in the journal Med showing that different patient responses to statins can be explained by the variation in the human microbiome. These findings suggest that microbiome monitoring could be used to help optimize personalized statin treatments.

Following his presentation, Gibbons answered a number of audience questions about the implications of his work. You can watch his Research Roundtable talk here or by playing the video above.

You can learn more about the research published in Med by watching our video featuring Gibbons and Dr. Tomasz Wilmanski, first author of the paper, here, or by playing the video below.

Research Roundtables

ISB hosts 10 or more Research Roundtable conversations each year to feature our leading scientists discussing their latest research. These free virtual events are designed for non-scientists, and are open to anyone interested in the topics.

Past Research Roundtable topics include long COVID, the impact of COVID-19 on pregnancy, Alzheimer’s Disease, finding drugs to treat Tuberculosis, identifying markers for cancer years before diagnosis, and many more.

You can explore all past Research Roundtable talks and our other events here.

Recent Articles

  • Dr. Sean Gibbons Promoted to Associate Professor

    Dr. Sean Gibbons – an expert in microbial ecology and evolution, computational systems biology, the human gut microbiome and its impacts on health, and head of ISB’s Gibbons Lab – has been promoted to Associate Professor. “Sean’s achievements since joining ISB in 2018 as a Washington Research Foundation Distinguished Investigator have been spectacular,” ISB President Dr. Jim Heath said. “With his focus on the microbiome, he brought a whole new…

  • The Gut Microbiome’s Supersized Role In Shaping Our Metabolome

    ISB researchers have shown which blood metabolites are associated with the gut microbiome, genetics, or the interplay between both. Their findings, published in the journal Nature Metabolism, have promising implications for guiding targeted therapies designed to alter the composition of the blood metabolome to improve human health.

  • Seattle Science Foundation and ISB

    ISB and Seattle Science Foundation Partner to Create Video Series

    What are multi-omics? Why does our microbiome matter? What’s the difference between genetics and genomics? What is a digital twin? ISB and Seattle Science Foundation have partnered to create videos answering questions like these and more, showcasing ISB scientists and their work.